Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/23373
Title: | Sweet's syndrome: Dilemma in febrile neutropenic patient with acute myeloid leukemia |
Authors: | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Dermatoloji Anabilim Dalı. Uludağ Üniversitesi/Tıp Fakültesi/Göz Hastalıkları Anabilim Dalı. 0000-0001-8889-1933 Özçelik, Tülay Özkocaman, Vildan Ali, Rıdvan Özkalemkaş, Fahir Özkan, Atilla Tunalı, Ahmet Bülbül-Başkan, Emel Yazıcı, Bülent AAG-8495-2021 AAH-1854-2021 7005424333 6603145040 7201813027 6601912387 6602518817 7005398015 9250698600 6602797853 |
Keywords: | Oncology Hematology |
Issue Date: | 2006 |
Publisher: | Pergamon-Elsevier Science |
Citation: | Özçelik, T. vd. (2006). ''Sweet's syndrome: Dilemma in febrile neutropenic patient with acute myeloid leukemia''. Leukemia Research, 30(11), 1466-1468. |
Abstract: | We read with great interest the article by Disel and colleagues [1] in a recent issue of Leukemia Research that described a case of acute myelogeneous leukemia (AML) with bilateral ear neutrophil poor Sweet's syndrome (SS). We would like to describe and share our experience in a patient with AML who developed bilateral eyelid SS and add some points concerning the SS. Sweet's syndrome, also referred to as febrile neutrophilic dermatosis, is characterized by fever, neutrophilic leukocytosis, painful red papules, nodules and plaques that respond readily to corticosteroid therapy [2], [3]. Although SS has been linked to hematologic malignancies, the frequency of SS with leukaemia is even lower in patients with neutropenia [4]. |
URI: | https://doi.org/10.1016/j.leukres.2006.01.019 https://www.sciencedirect.com/science/article/pii/S0145212606000543 http://hdl.handle.net/11452/23373 |
ISSN: | 0145-2126 |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.